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Background. Necrotizing and crescentic glomerulonephritis
related to antineutrophil cytoplasmic autoantibodies (ANCA)
is typically referred to as “pauci-immune”; however, it is not
unusual for renal biopsies in such cases to exhibit some im-
mune complex deposition within glomeruli on immunofluo-
rescence and/or electron microscopic study. The composition
and intraglomerular localization of such deposits in ANCA-
glomerulonephritis has not been widely studied, and their po-
tential pathologic and clinical significance is not clear, although
a possible synergistic effect between immune complexes and
ANCA in producing more severe glomerulonephritis is sug-
gested by some human and animal studies.
Methods. Electron micrographs from 126 renal biopsies
showing necrotizing/crescentic glomerulonephritis character-
ized by positive ANCA serology [C-ANCA, anti-proteinase 3
(anti-PR3), or anti-myeloperoxidase (MPO)] or necrotizing ar-
teritis in the absence of known ANCA results were examined
for the presence, quantity, and location of electron-dense de-
posits. The presence or absence of such deposits was correlated
with histologic findings (fraction of glomeruli with crescents and
segmental necrotizing lesions, mesangial and endocapillary hy-
percellularity), immunofluorescence findings, and clinical data,
including serum creatinine and 24-hour urine protein levels at
the time of biopsy.
Results. Sixty-eight (54%) of these biopsies showed glomeru-
lar immune complex deposits on electron microscopy; 87% of
the latter also showed positive immunofluorescence findings
for at least one immunoglobulin or complement component,
although staining was relatively mild in most instances (≤2+
on a 0 to 4+ scale in all but eight cases). Nearly half of biopsies
negative for deposits by electron microscopy also showed posi-
tive immunofluorescence findings, though even more so than in
cases with deposits on electron microscopy the intensity of im-
munofluorescence staining in these biopsies was typically very
weak (trace or trace to 1+ in most cases, none >2+). Hypercel-
lularity within the glomerular tuft was seen in 50% of biopsies
with deposits on electron microscopy but only 14% of those
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without deposits; in each group this was usually mild and mesan-
gial. Notably, the presence of deposits on electron microscopy
was associated with a higher median level of proteinuria (3.2
versus 1.3 g/24 hours, P < 0.0001) and a higher median per-
centage of glomeruli with crescents (62.5% versus 44.0%, P =
0.06).
Conclusion. Immune complex deposits were found on elec-
tron microscopy in just over half of renal biopsies with crescen-
tic glomerulonephritis associated with positive ANCA serology
and/or necrotizing arteritis. Clinical correlations suggest that
these immune complex deposits may somehow potentiate the
effect of ANCA in producing glomerulonephritis.
Crescentic glomerulonephritis is generally divided
into three immunopathologic categories: (1) glomeru-
lonephritis with antibodies directed against the glomeru-
lar basement membrane (GBM) (anti-GBM nephritis),
characterized by linear staining for IgG and usually C3
along the glomerular capillary loops by immunofluo-
rescence microscopy and an absence of electron-dense,
immune complex deposits by electron microscopy; (2) im-
mune complex-mediated glomerulonephritis, represent-
ing severe forms of various types of glomerulonephritis
such as postinfectious glomerulonephritis, IgA nephropa-
thy, and lupus nephritis, characterized by granular
glomerular staining for one or more immunoglobu-
lins and/or complement components by immunofluores-
cence and multiple electron-dense deposits by electron
microscopy; and (3) pauci-immune glomerulonephritis,
which is characterized by mild or absent glomerular tuft
staining for immunoglobulins and/or complement by im-
munofluorescence and few or no electron-dense deposits
by electron microscopy [1, 2]. The great majority (approx-
imately 80% to 85%) of cases of pauci-immune crescentic
(or often, necrotizing and crescentic) glomerulonephri-
tis are associated with circulating antineutrophil cyto-
plasmic autoantibodies (ANCA) directed against either
myeloperoxidase (MPO) or proteinase 3 (PR3) and the
majority are associated with systemic small-vessel vas-
culitis (microscopic polyangiitis, Wegener’s granulomato-
sis, or Churg-Strauss syndrome) [1, 3]. Recent evidence
indicates that ANCA are almost certainly involved in
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the pathogenesis of both the glomerulonephritis and the
small vessel vasculitis [4–6].
Although the terms ANCA-associated necrotizing/
crescentic glomerulonephritis (or simply ANCA-glo-
merulonephritis) and pauci-immune necrotizing/
crescentic glomerulonephritis have become virtually
synonymous, it is nevertheless not unusual for some
glomerular immune complex deposits to be present in
such lesions [7–11]. Still, studies of the incidence of
immune complex deposits in ANCA-glomerulonephritis
have been limited, often consisting of small case se-
ries as recently reviewed by Neumann et al [10] and
Brons, Kallenberg, and Cohen Tervaert [11]. Ronco
et al [9] found C3 deposits, typically mesangial and
often without accompanying immunoglobulin, in re-
nal biopsies from 12 of 43 patients with Wegener’s
granulomatosis or microscopic polyangiitis. Harris,
Falk and Jennette [8] [abstract; Jennette JC, et al, J
Am Soc Nephrol 7:1735, 1996] found immunoglobulin
deposits by immunofluorescence in 64/142 (45%) cases
of crescentic glomerulonephritis in patients positive for
anti-MPO or anti-PR3, although only five of these 64
cases showed strong (>2+ on a 0 to 4+ scale) staining
for any immunoglobulin and only 10 had electron-dense
deposits on electron microscopy. Accordingly, Falk
and Jennette [7] have recommended that the term
pauci-immune be used when there is ≤2+ staining for
any immunoglobulin by immunofluorescence and an
absence of deposits by electron microscopy. Neumann
et al [10] recently reported that biopsies from eight of 45
patients with ANCA-glomerulonephritis showed ≥2+
mesangial and/or glomerular capillary loop staining
for IgA and/or IgM, with C3 and/or C1q staining in
seven of these cases and electron-dense deposits in all
five cases that were examined by electron microscopy.
Some cases of ANCA-glomerulonephritis with more
than mild immune complex deposition may represent
ANCA-glomerulonephritis superimposed on a second,
immune complex-related glomerular disease such as IgA
nephropathy, postinfectious glomerulonephritis, or mem-
branous nephropathy [12–14] [abstract; Jennette JC, et al,
Lab Invest 74:167A, 1996].
It has been suggested that immune complexes may
act synergistically with ANCA to produce more severe
glomerulonephritis than is seen with ANCA or immune
complexes alone [7, 10, 11, 15]. Consistent with this
are findings that various forms of immune complex-
related glomerulonephritis in ANCA-positive patients
are more likely to show necrotizing and crescentic le-
sions than similar lesions in ANCA-negative patients
[16] [abstract; Jennette JC, et al, Lab Invest 74:167A,
1996], and that cases of ANCA-glomerulonephritis with
at least moderate immune complex deposition are as-
sociated with greater proteinuria than pauci-immune
ANCA-glomerulonephritis [10]. The significance of mild
immune complex deposition on the severity of ANCA-
glomerulonephritis has not been similarly studied.
However, it is of interest that in a model of ANCA-
glomerulonephritis in which Rag2−/− mice lacking func-
tioning B and T lymphocytes were given splenocytes
that secrete anti-MPO antibody, mild to moderate, pre-
dominantly mesangial immune complex deposition oc-
curred together with severe glomerular lesions typical of
ANCA-glomerulonephritis. By contrast, mice receiving
similar titers of anti-MPO antibody without splenocytes
did not develop immune complex deposits, and had far
fewer glomeruli with necrotizing and crescentic lesions
[6].
In this study, we examined the frequency of immune
complex deposits in 126 renal biopsies with crescen-
tic glomerulonephritis associated with positive ANCA
serology and/or necrotizing small vessel arteritis, and
found immune complex deposits by electron microscopy
in 54% of the biopsies, although these were often few in
number. Nonetheless, these cases were associated with
more frequent glomerular tuft hypercellularity, greater
proteinuria, and trends toward higher serum creatinine
level and more widespread crescent formation compared
with cases lacking deposits on electron microscopy.
METHODS
Computerized records of the Department of Pathol-
ogy, Johns Hopkins Hospital, were reviewed to iden-
tify those renal biopsies that were received on the
Johns Hopkins renal biopsy service from January 1993
through December 2002 with a diagnosis of pauci-
immune or ANCA-associated crescentic and/or necro-
tizing glomerulonephritis, Wegener’s granulomatosis, or
microscopic polyangiitis on which electron microscopy
was performed. These search terms were used specif-
ically to exclude cases where there was a severe, pri-
mary immune complex glomerulonephritis (e.g., acute
postinfectious glomerulonephritis, membranoprolifera-
tive glomerulonephritis, crescentic IgA nephropathy) or
a systemic disease other than an ANCA-associated vas-
culitis [e.g., systemic lupus erythematosus with lupus
nephritis, Henoch-Scho¨nlein purpura (HSP) with HSP
nephritis] that likely accounted for the crescentic and/or
necrotizing glomerulonephritis present. Cases with anti-
GBM antibody nephritis were also not considered for this
study. For each case identified, the biopsy report and clin-
ical data submitted with the biopsy were reviewed and
only those cases meeting one of the two following cri-
teria were included in this study: (1) positive C-ANCA
and/or anti-PR3, or anti-MPO serology, or (2) presence of
necrotizing arteritis in addition to necrotizing and/or cres-
centic glomerulonephritis on the biopsy with unknown
ANCA serology or positive P-ANCA. All but three cases
with positive anti-MPO serology also had a documented
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positive P-ANCA (in these three cases P-ANCA and
C-ANCA results were not available), and 25 of 49 cases
with positive C-ANCA had documented anti-PR3 serol-
ogy. A positive P-ANCA by indirect immunofluorescence
without documented anti-MPO or necrotizing arteritis
was not sufficient for inclusion, as Lim et al [17] found
P-ANCA to be frequently positive in most glomerular
diseases, including over 70% of cases of lupus nephri-
tis, approximately 15% of cases of IgA nephropathy and
membranoproliferative glomerulonephritis, and approx-
imately 20% of cases of membranous and minimal change
nephropathies. By contrast, C-ANCA, anti-MPO, and
anti-PR3 were present only rarely or not at all in these
five diseases [17]. A total of 126 biopsies meeting these
criteria were identified, 125 of which were native kid-
ney biopsies and one a renal transplant biopsy. No repeat
biopsies were included.
Each of the cases was then assigned a number from
1 to 126. The renal biopsy reports and clinical data
were again reviewed, and the following data recorded
on spread sheets containing only this number: glomeru-
lar immunofluoresence findings for IgG, IgA, IgM, C3,
and C1q (graded on an intensity scale from 0 to 4+),
patient age, gender, and race, and where listed serum
creatinine and 24-hour urine protein levels at the approx-
imate time of the biopsy. Following this, electron micro-
graphs from each biopsy were reviewed by one of the
authors (M.H.), blinded to the clinical and immunoflu-
orescence data. There were a minimum of six elec-
tron micrographs per biopsy, including at least one
low-power micrograph comprising several capillary loops
and mesangial areas. In over 70% of the cases, the
electron micrographs were taken by an attending re-
nal pathologist. In the remaining cases the electron
micrographs were taken by an electron microscopy
technician with over 25 years of experience in ultrastruc-
tural examination of renal biopsies, with specific instruc-
tions to take random photographs of each glomerulus
present and to photograph deposits and other abnor-
malities when present. Amounts of electron-dense de-
posit in mesangial, subepithelial/intramembranous, and
subendothelial locations were graded according to the
following scale: 0, absent; 1, deposits in 1 to 3 mesan-
gial regions or glomerular capillaries; 2, more deposits
than grade 1 but involving fewer than 50% of mesan-
gial regions or glomerular capillaries; and 3, deposits in
>50% of mesangial regions or glomerular capillaries. De-
posits in scarred areas of glomeruli with an appearance
consistent with plasma insudation (hyalinosis) were not
graded. In two cases the renal biopsy report noted the
presence of mesangial deposits but none were seen on the
electron micrographs; in these cases the original electron
microscopy grids were reexamined in the electron mi-
croscope and in both cases rare mesangial deposits were
identified.
After review of the electron micrographs was com-
pleted, histologic slides from each biopsy [stained with
hematoxylin-eosin, periodic acid-Schiff (PAS), silver
methenamine, and Masson’s trichrome stains] were la-
beled with the case number (1 to 126) and reviewed by
a renal pathologist (M.H.) blinded to the clinical, im-
munofluorescence, and electron microscopy data. For
each biopsy the following information was recorded
based on review of the slides stained with silver
methenamine and trichrome stains, which are routinely
performed on consecutive tissue sections: number of
glomeruli (excluding globally sclerotic glomeruli), num-
ber of glomeruli with segmental necrotizing lesions, and
number of glomeruli with cellular, fibrocellular, and fi-
brous crescents. In addition, for each biopsy a glomeru-
lar cellularity score grading the severity of mesangial and
endocapillary hypercellularity was determined according
to the following scale: 0, no mesangial or endocapillary
hypercellularity; 1, focal (involving <50% of glomeruli)
mesangial hypercellularity; 2, diffuse (involving >50%
of glomeruli) mesangial or focal endocapillary hyper-
cellularity; 3, diffuse mesangial and focal endocapillary
hypercellularity; and 4, diffuse endocapillary hypercellu-
larity. Mesangial hypercellularity was defined as >4 cells
in one or more mesangial regions in portions of glomeruli
not adjacent to the vascular pole on 3 lm thick sections.
Endocapillary hypercellularity was defined as complete
or near-complete occlusion of one or more glomerular
capillaries by cells other than neutrophils or small lym-
phocytes, in portions of glomeruli not directly adjacent
to crescents or areas of necrosis. In this study, all biopsies
with endocapillary hypercellularity also showed mesan-
gial hypercellularity.
Statistical analysis
Clinical and pathologic data, devoid of personal iden-
tifiers, were entered into an electronic database and the
accuracy of data transcription was independently con-
firmed. The distribution of variables was examined using
the Shapiro-Wilks test and q-q plots. Outlying values were
identified using box plots and their accuracy checked
against the original source data. Normally distributed
continuous data were summarized using means and stan-
dard deviations (SD) and were compared across groups
using independent sample t tests. Markedly skewed data
were summarized as medians and were compared across
groups using the Mann-Whitney test. Categorical data
were compared using Fisher’s exact test (for 2 × 2 tables)
or Pearson’s chi-square test. Analyses were performed
using SPSS Base 7.5 (SPSS Inc., Chicago, IL, USA).
All study procedures were approved by the Joint
Committee on Clinical Investigation of Johns Hopkins
Hospital.
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Table 1. Serologic, demographic, and clinical characteristics in cases
with and without immune complex deposits by electron microscopy
Immune complex deposits
by electron microscopy
Present Absent P value
Number of biopsies (%) 68 (54) 58 (46)
Anti-myeloperoxidase (MPO) 39 24 0.09a
C-antineutrophil cytoplasimic 22 27
autoantibodies (ANCA)/
anti-proteinase 3 (PR3)
ANCA unknown, vasculitis presentb 7 7
Patient age (mean ± SD) years 60 ± 16 59 ± 17 NSc
Gender male/female 38/30 31/27 NSd
Serum creatinine (median) mg/dL 4.1 (57) 2.8 (45) 0.10e
(number of cases)
Serum creatinine, (mean ± SD) mg/dL 4.8 ± 3.1 3.6 ± 2.4
Urine protein, g/24 hours (median) 3.2 (38) 1.3 (38) .0001e
(number of cases)
Urine protein, g/24 hours (mean ± SD) 3.7 ± 3.1 1.6 ± 1.3 .0001c
NS is not significant (P > 0.10).
aFisher exact test; only cases with known anti-MPO or C-ANCA/anti-PR3 are
included; bNecrotizing arteritis (13 cases) or necrotizing arteritis and medullary
capillaritis (one case); ct test; dFisher exact test; eMann-Whitney test.
RESULTS
Of the 126 biopsies examined, 68 (54%) showed
some immune complex deposits by electron microscopy
(Table 1). There was no significant association between
the presence or absence of deposits and patient age, gen-
der, or type of ANCA present, although there was a trend
toward an association between anti-MPO and cases with
deposits. Among those 76 patients with known 24-hour
urine protein levels, the mean and median levels of pro-
teinuria were significantly greater in those patients whose
biopsies showed deposits, similar to findings reported by
Neumann et al [10]. There was also a trend toward higher
serum creatinine levels in patients whose biopsies showed
deposits, although this did not reach statistical signifi-
cance (Table 1).
The presence or absence of deposits by electron mi-
croscopy could not be accounted for by the number
of glomeruli examined ultrastructurally, which ranged
from 1 to 4 in different biopsies. The mean numbers of
glomeruli examined by electron microscopy and by light
microscopy were nearly identical between cases with and
without deposits (Table 2). The great majority (87%) of
biopsies with deposits by electron microscopy also had
deposits by immunofluorescence. Surprisingly, nearly half
of biopsies without deposits also showed staining within
the glomerular tuft for at least one immunoglobulin or
complement component. However, as shown in Tables 2
and 3, only 13 (22%) of the 58 biopsies without deposits
on electron microscopy showed 1+ or greater staining
for any immune reactant, and none showed more than
2+ staining. By contrast, 75% of biopsies with deposits
on electron microscopy showed ≥1+ staining for at least
one immunoglobulin or complement component, with
Table 2. Renal biopsy findings in cases with and without immune
complex deposits by electron microscopy
Immune complex deposits
by electron microscopy
Present Absent P value
Number of biopsies (%) 68 (54) 58 (46)
Number of glomeruli on histology 21 ± 13 20 ± 18 NSb
(mean ± SD)a
Number of glomeruli on electron 1.7 ± 0.8 1.8 ± 0.8 NSb
microscopy (mean ± SD)
Number positive by 58 (87) 26 (45) 0.0001d
immunofluorescencec (%)
Number ≥1+ by 50 (75) 13 (22) 0.0001d
immunofluorescencec (%)
Number ≥1+ with >1 antibody by 37 (55) 5 (9) 0.0001d
immunofluorescence (%)
Number with necrotizing 15 (22) 13 (22) NSd
arteritis (%)
% of glomeruli with necrosis 14.5 15.0 NSe
(median)a
% of glomeruli with crescents 62.5 44.0 0.06e
(median)a
Glomerular cellularity score, number
of biopsies (%)
0 34 (50) 50 (86) 0.0001f
1 27 (40) 7 (12)
≥2 7 (10) 1 (2)
NS is not significant (P > 0.10).
aOn silver methenamine- and trichrome-stained slides; see Methods section;
bt test; cPositive with antibody to at least one of the following: IgG, IgA,
IgM, C3, C1q. Immunofluorescence was not done on one case with immune
complex deposits by electron microscopy. Linear capillary loop IgG and C3
deposits in a single case of combined antineutrophil cytoplasmic autoantibodies
(ANCA)-glomerulonephritis and anti-glomerular basement membrane (GBM)
nephritis are not counted among the positive immunofluorescence results;
this case did not have deposits on electron microscopy; dFisher exact test;
eMann-Whitney test; fPearson’s chi-square test.
≥1+ staining for more than one immune reactant in 55%
and >2+ staining for at least one in eight cases (12%).
In biopsies with and without deposits by electron mi-
croscopy, immunofluorescence staining was most often
seen for IgM and C3, and rarely for C1q. However, while
staining for IgG and IgA was very rare in cases without
electron microscopy deposits, such staining was seen in
25% and 22%, respectively, of biopsies showing deposits
by electron microscopy (Table 3).
There was no difference between biopsies with and
without electron-dense deposits with regard to the frac-
tion of cases with necrotizing arteritis and the median per-
centage of glomeruli with segmental necrotizing lesions.
However, the median percentage of glomeruli with cres-
cents was 62.5% in cases with deposits versus 44.0% in
cases without deposits, a difference that is just short of sta-
tistical significance (Table 2). Not surprisingly, glomerular
cellularity scores indicative of mesangial and/or endocap-
illary hypercellularity were higher in cases with deposits,
consistent with findings that glomerular hypercellularity
tends to be greater in immune complex-related forms
of glomerulonephritis than in pauci-immune glomeru-
lonephritis [1].
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Table 3. Immunofluorescence findings in biopsies with and without
immune complex deposits by electron microscopy
Immune complex deposits
by electron microscopy
Present Absent P valuea
IgG Number positive (%) 17 (25) 2 (3) 0.001
Number ≥1+ (%) 10 (15) 0 0.002
Number >2+ (%) 2 (3) 0
IgA Number positive (%) 15 (22) 1 (2) 0.0001
Number ≥1+ (%) 12 (18) 0 0.0001
Number >2+ (%) 1 (1) 0
IgM Number positive (%) 41 (61) 21 (36) 0.01
Number ≥1+ (%) 28 (42) 6 (10) 0.0001
Number >2+ (%) 1 (1) 0
C3 Number positive (%) 51 (76) 20 (34) 0.0001
Number ≥1+ (%) 44 (66) 12 (21) 0.0001
Number >2+ (%) 6 (9) 0
C1q Number positive (%) 8 (12) 2 (3) NS
Number ≥1+ (%) 2 (3) 0 NS
Number >2+ (%) 0 0
Linear capillary loop IgG and C3 deposits in a single case of combined
antineutrophil cytoplasmic autoantibodies (ANCA)-glomerulonephritis and
anti-glomerular basement membrane (GBM) nephritis are not counted among
the positive immunofluorescence results; this case did not have deposits on
electron microscopy. Immunofluorescence was not done on one of the 68 biopsies
with immune complex deposits by electron microscopy.
aFisher exact test; no statistical analysis was done comparing numbers of
biopsies with >2+ staining because of the small numbers of such cases. NS is not
significant (P > 0.10).
Table 4. Location and numbers of immune complex deposits by
electron microscopy
Number of
Location of deposits cases (%)
Mesangial only 22 (32)
Subepithelial/intramembranous only 4 (6)
Mesangial and subepithelial/intramembranous 36 (53)
Mesangial and subendothelial 1 (1)
Mesangial, subepithelial/intramembranous, 5 (7)
and subendothelial
Deposit score
0 1 2 3
Mesangial 4 31 32 1
Subepithelial/intramembranous 23 36 7 2
Subendothelial 62 6 0 0
Only those 68 biopsies showing deposits on electron microscopy are included
in this table. Numbers listed in the lower portion of the table represent numbers
of biopsies.
Table 4 summarizes the location and number of im-
mune complex deposits seen by electron microscopy. In
most cases showing deposits, these were limited to mesan-
gial or to mesangial plus subepithelial/intramembranous
locations; subendothelial deposits were rare. Moderate
numbers of mesangial deposits were seen in nearly half
of these cases, although subepithelial/intramembranous
and subendothelial deposits, when present, tended to be
few in number. Two biopsies, one of which is shown
in Figure 1A to C, showed numerous subepithelial
deposits (deposit score 3), as well as 3+ glomerular
capillary loop staining for IgG. These cases are felt to
represent ANCA-glomerulonephritis superimposed on
membranous nephropathy. Ten biopsies showed subep-
ithelial deposits, often partially resorbed, in “notch” re-
gions between adjacent glomerular capillaries; in five of
these a moderate number of such deposits (deposit score
2) were present. One of the latter biopsies is shown in
Figure 1D to F. All 10 of these biopsies also showed
mesangial deposits by electron microscopy (deposit score
2 or 3 in eight cases) and ≥1+ C3 staining by immunoflu-
orescence (≥2+ in eight cases). It is thought that these
cases most likely represent ANCA-glomerulonephritis
superimposed on partially or largely healed postinfec-
tious glomerulonephritis [13].
Omitting the 12 cases with ANCA-glomerulonephritis
superimposed on membranous nephropathy or partially
healed postinfectious glomerulonephritis plus the one
case with >2+ IgA staining (likely representing ANCA-
glomerulonephritis superimposed on IgA nephropathy)
did not change the association of immune complex de-
posits with higher levels of proteinuria, serum creatinine,
and the fraction of glomeruli with crescents. Not includ-
ing these 13 cases, patients whose biopsies showed de-
posits by electron microscopy had a significantly higher
median 24-hour urine protein level (2.7 g versus 1.3 g,
P < 0.001), a significantly higher median serum creati-
nine level (4.2 mg/dL versus 2.8 mg/dL, P = 0.017), and
a trend toward a higher median percentage of glomeruli
with crescents (61.0% versus 44.0%, P = 0.092) compared
with patients whose biopsies did not show deposits by
electron microscopy.
The association of the presence of immune complex
deposits by electron microscopy with higher levels of
serum creatinine, greater urine protein excretion, and a
higher fraction of glomeruli with crescents was also main-
tained when those 14 biopsies with necrotizing arteritis
but unknown ANCA serology were omitted from the
analysis. Indeed, when these latter biopsies were omitted
the differences between cases with and without deposits
were statistically significant for all three parameters (all
ANCA-positive, Table 5). When considering patients ac-
cording to type of ANCA serology, the median serum
creatinine, 24-hour urine protein excretion, and fraction
of glomeruli with crescents was higher in cases with de-
posits than without in each ANCA subgroup, although
not all of these differences were statistically significant,
perhaps due in large part to relatively small numbers of
patients within some subgroups (Table 5).
DISCUSSION
In this study, electron microscopic examination of 126
cases of crescentic glomerulonephritis associated with
ANCA and/or necrotizing arteritis showed the presence
of electron-dense deposits typical of immune complexes
in 68 (54%). The overwhelming majority of these cases
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Fig. 1. Light, immunofluorescence and elec-
tron microscopic findings from cases of
antineutrophil cytoplasmic autoantibodies
(ANCA)-glomerulonephritis superimposed
on membranous nephropathy (A–C) and
on largely healed postinfectious glomeru-
lonephritis (D–F). (A) Glomeruli showing
fibrinoid necrosis (arrow, left) and a segmen-
tal cellular crescent (right), both with thicken-
ing of glomerular capillary loops that is most
clearly evident at the lower left (Masson’s
trichrome stain, original magnification ×200).
(B) Immunofluorescence showing confluent
granular glomerular capillary loop staining
for IgG, 3+ on a 0 to 4+ scale [fluores-
cein isothiocyanate (FITC)-conjugated anti-
human IgG, original magnification ×400]. (C)
Electron microscopy showing multiple subep-
ithelial electron-dense deposits, some ap-
pearing partially resorbed, with extension of
the glomerular basement membrane (GBM)
around the deposits (uranyl acetate and lead
citrate stain, original magnification ×6300).
(D) Two glomeruli, one (left) with a cir-
cumferential, fibrocellular crescent. Although
the tuft of the latter glomerulus is com-
pressed, neither glomerulus shows significant
mesangial or endocapillary hypercellularity,
although elsewhere in the biopsy occasional
glomeruli showed mild mesangial hypercel-
lularity [periodic acid-Schiff (PAS) stain,
original magnification ×200]. (E) Immunoflu-
orescence for C3 shows global, coarse gran-
ular staining in a predominantly mesangial
pattern, 3 to 4+ on a 0 to 4+ scale (FITC-
conjugated antihuman C3, original magnifica-
tion ×400). (F) Electron microscopy showing
a large subepithelial deposit in a “notch” area
(arrow), as well as mesangial deposits (uranyl
acetate and lead citrate stain, original magni-
fication ×3800).
showed staining for immunoglobulins and/or C3 by im-
munofluorescence. The 10 biopsies that were negative
by immunofluorescence each showed only rare deposits
by electron microscopy (deposit score of 1 in mesangial
and/or subepithelial/intramembranous locations). While
it is possible that the deposits in these cases represent
insudative lesions, we did not grade hyaline-like deposits
in scarred areas of glomeruli during review of the elec-
tron micrographs, and in addition such lesions usually
exhibit some staining for IgM. Notably, only eight biop-
sies showed more than 2+ staining for any immunoglob-
ulin and/or C3, reflecting the relatively modest number
of deposits seen by electron microscopy in the majority of
cases. No biopsy lacking deposits on electron microscopy
showed >2+ staining for any immunoglobulin or C3. As
such, and consistent with findings of others [8–10], the
great majority of cases in this study could be regarded as
pauci-immune, although it should be emphasized that the
latter term should not be taken as indicating a complete
lack of immune complex deposits.
This study was designed to exclude cases of severe,
crescentic immune complex-mediated glomerulonephri-
tis by restricting the terms used in our initial search of
computerized records and by not including cases with a
positive P-ANCA by indirect immunofluorescence with-
out documented anti-MPO or necrotizing arteritis; such
P-ANCA positivity is not infrequently seen in crescentic,
immune complex-mediated glomerulonephritis [7, 17].
While in a minority of our cases with immune complex
deposits, including those with the greatest numbers of
deposits, the immune complex deposition present ap-
pears to represent a disease process distinct from ANCA-
glomerulonephritis, such as membranous nephropathy
or postinfectious glomerulonephritis, these cases are felt
to represent ANCA-glomerulonephritis superimposed
on immune complex-mediated glomerular lesions, an
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Table 5. Association of antineutrophil cytoplasmic autoantibodies (ANCA) serology with serum creatinine levels, proteinuria, and crescents in
cases with and without immune complex deposits by electron microscopy
Median serum creatinine Median urine protein Median % glomeruli
mg/dL g/24 hours with crescents
Deposits + − + − + −
All ANCA-positive (112) 4.2 (51) 2.9 (40) 3.0 (37) 1.4 (35) 62.0 (61) 44.0 (51)
P value 0.025 0.001 0.043
Anti-MPO (63) 4.4 (30) 2.7 (16) 3.4 (24) 1.2 (18) 55.0 (39) 43.5 (24)
P value 0.128 0.011 0.174
All C-ANCA (49) 3.9 (21) 3.0 (24) 2.8 (13) 1.5 (17) 65.5 (22) 44.0 (27)
P value 0.088 0.043 0.134
C-ANCA and anti-PR3 (25) 4.3 (12) 2.9 (12) 3.0 (7) 1.2 (7) 67.0 (13) 34.5 (12)
P value 0.078 0.128 0.247
Anti-MPO and anti-PR3 (88) 4.4 (42) 2.8 (28) 3.3 (31) 1.2 (25) 61.0 (52) 42.5 (36)
P value 0.018 0.002 0.057
Arteritis, ANCA Unknown (14) 3.0 (6) 2.0 (5) 4.0 (1) 0.6 (3) 64.0 (7) 64.0 (7)
P value 0.126 NS NS
Abbreviations are: MPO, myelperoxidase; PR3, proteinase 3.
Numbers in parentheses represent the number of biopsies in each category. P values are by Mann-Whitney test. NS is not significant.
occurrence well documented in the literature [12–
14]. However, the relationship of the generally
low-level immune complex deposition to the ANCA-
glomerulonephritis in the remaining cases remains un-
clear. Brons, Kallenberg, and Cohen Tervaert [11] and
Brons et al [18] have postulated that immune com-
plexes are deposited very early in the course of ANCA-
glomerulonephritis and vasculitis and may play a role in
initiation of the disease process, although the deposits
are usually removed from the severe inflammatory le-
sion before a biopsy is performed. Consistent with this,
they detected IgG and/or IgA deposits in eight of 32
biopsies of skin lesions taken at the initial presentation
or onset of a relapse of Wegener’s granulomatosis, al-
though renal biopsies performed in four of these eight
cases all showed pauci-immune necrotizing and crescen-
tic glomerulonephritis [18]. Transient immune complex
deposition was observed in an animal model of ANCA-
glomerulonephritis involving injection of rats with
human MPO. MPO-anti-MPO immune complexes were
observed within glomeruli after 24 hours but had largely
disappeared by 10 days after injection [19]. In the present
study, we did not observe a difference between biopsies
with and without electron-dense deposits in either the
fraction of glomeruli with necrotizing lesions or the mean
fraction of crescents present that were cellular rather than
fibrocellular or fibrous (50% versus 48%, respectively, in
cases with and without deposits). While these findings
could be interpreted as being inconsistent with the hy-
pothesis of Brons, Kallenberg, and Cohen Tervaert [11]
and Brons et al [18], a far more systematic approach, per-
haps even one involving serial biopsies, would be needed
to truly test this hypothesis in a clinical setting.
The findings in this study are, however, consistent with
earlier results in both humans and animal models suggest-
ing that the presence of immune complexes potentiates
the effect of ANCA in promoting glomerulonephritis.
Like Neumann et al [10], we found significantly higher
levels of proteinuria in those patients whose biopsies
had immune complex deposits than in those whose
biopsies lacked such deposits. Neumann et al [10] also
observed a trend toward worse outcome with respect
to renal function in cases with deposits, and consis-
tent with this we observed a trend toward higher serum
creatinine levels at the time of biopsy in cases with
deposits, the serum creatinine being a strong predictor
of renal outcome in ANCA-glomerulonephritis [20]. We
also observed a trend toward a greater percentage of cres-
cents in biopsies with deposits; some investigators have
found the fraction of glomeruli with crescents to be a sig-
nificant predictor of renal survival [21] however others
have not [20, 22]. Our findings were not changed by ex-
cluding 13 cases with ANCA-glomerulonephritis super-
imposed on membranous nephropathy, partially healed
postinfectious glomerulonephritis, or IgA nephropathy
from the data analysis, nor were the findings changed by
omitting those 14 cases with necrotizing arteritis but un-
known ANCA serology. In fact, the association between
deposits on electron microscopy and higher serum cre-
atinine reached statistical significance in the latter two
analyses.
In a recently developed model of ANCA-
glomerulonephritis and vasculitis, Rag2−/− mice,
which lack functioning B and T lymphocytes, were found
to develop severe necrotizing and crescentic glomeru-
lonephritis (crescents in 48% to 99% of glomeruli) when
injected with splenocytes taken from MPO knockout
mice that had earlier been immunized with mouse MPO
[6]. However, the glomerulonephritis developed by the
Rag2−/− mice injected with anti-MPO splenocytes was
not truly pauci-immune; mild to moderate immune com-
plex deposition was observed by immunofluorescence
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and electron microscopy, mainly though not exclusively
in mesangial areas. Immune complex deposition was
also observed in Rag2−/− mice given splenocytes
from mice immunized with bovine serum albumin
rather than MPO, although these Rag2−/− mice did
not develop glomerular necrosis or crescents. Notably,
Rag2−/− mice injected with similar titers of anti-MPO
antibody to those observed in mice receiving anti-MPO
splenocytes developed only very focal necrotizing and
crescentic glomerulonephritis (crescents in 5% to 15%
of glomeruli); these latter mice also did not develop
glomerular immune complex deposits [6]. These findings
suggest a synergy between immune complexes and
ANCA in producing glomerulonephritis, and are con-
sistent with this and other human renal biopsy studies
suggesting a similar synergy [10, 16] [abstract; Jennette
JC et al, Lab Invest 74:167A, 1996]. Further work with
this mouse model may help uncover the mechanism(s)
underlying such an effect.
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